MedTrace Logo

French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)

NCT04328298 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2026-03-04

No results posted yet for this study

Summary

This study is a registry including prospective and retrospective data on all patients who have been presented in a Multidisciplinary tumor board or RCP to be eligible for CAR-T cell treatment.

Conditions

  • Hematopathology Eligible or CAR-t Cell Treatment

Sponsors & Collaborators

Principal Investigators

  • Steven LE GOUILL, Pr · Institut Curie

  • Roch HOUOT, Pr · CHU Pontchaillou

Eligibility

Min Age
0 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-19
Primary Completion
2038-12-19
Completion
2038-12-19

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04328298 on ClinicalTrials.gov